Cargando...

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany

AIM: This study aimed to compare 6-month adherence to therapy with exenatide once weekly (Bydureon(®)) vs liraglutide once daily (Victoza(®)) in patients with type 2 diabetes under primary care in Germany. METHODS: A nationwide longitudinal prescription database (LRx), (between January 2011 and Sept...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Metab Syndr Obes
Main Authors: Qiao, Qing, Ouwens, Mario JNM, Grandy, Susan, Johnsson, Kristina, Kostev, Karel
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2016
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4934555/
https://ncbi.nlm.nih.gov/pubmed/27418849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S99732
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!